NPCE

Neuropace Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 1/10
Neuropace sales and earnings growth
NPCE Growth
Good
  • Revenue Y/Y↑ 25.13%
  • EPS Y/Y↑ 29.03%
  • FCF Y/Y↑ 37.89%
Neuropace gross and profit margin trends
NPCE Profitability
Neutral
  • Gross margin ↑ 77.20%
  • EPS margin↓ -21.50%
  • ROIC 5Y↓ -15.08%
Neuropace net debt vs free cash flow
NPCE Risk
Poor
  • Debt / Equity↑ 3.7
  • Debt / FCF↓ 4.3
  • Interest coverage↓ -1.9

Neuropace stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Medical Devices stocks ↗